These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24354448)

  • 1. Effectiveness and safety of rapid clozapine titration in schizophrenia.
    Ifteni P; Nielsen J; Burtea V; Correll CU; Kane JM; Manu P
    Acta Psychiatr Scand; 2014 Jul; 130(1):25-9. PubMed ID: 24354448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia.
    Poyraz CA; Özdemir A; Sağlam NG; Turan Ş; Poyraz BÇ; Tomruk N; Duran A
    Psychiatr Q; 2016 Jun; 87(2):315-22. PubMed ID: 26433727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid clozapine titration in treatment-refractory bipolar disorder.
    Ifteni P; Correll CU; Nielsen J; Burtea V; Kane JM; Manu P
    J Affect Disord; 2014 Sep; 166():168-72. PubMed ID: 25012427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing treatment with clozapine.
    Conley RR
    J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility and Safety of Slower-than-Recommended Titration of Clozapine for Treatment-Resistant Schizophrenia: a Retrospective Cohort Study.
    Tsukahara M; So R; Yada Y; Kodama M; Kishi Y
    Psychiatr Q; 2021 Jun; 92(2):703-713. PubMed ID: 32889690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
    Nyakyoma K; Morriss R
    Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination?
    Flamarique I; Castro-Fornieles J; Garrido JM; de la Serna E; Pons A; Bernardo M; Baeza I
    J Clin Psychopharmacol; 2012 Dec; 32(6):756-66. PubMed ID: 23131877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
    J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary flow rate in patients with schizophrenia on clozapine.
    Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK
    Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
    Davis MC; Fuller MA; Strauss ME; Konicki PE; Jaskiw GE
    Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim
    J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].
    Enomoto T; Ito T; Sekine K; Yasui R; Ashizawa Y; Uju Y; Hayakawa T; Tsukada K
    Seishin Shinkeigaku Zasshi; 2013; 115(9):953-66. PubMed ID: 24228473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.